These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6434435)

  • 1. Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men.
    Schürmeyer T; Nieschlag E
    Int J Androl; 1984 Jun; 7(3):181-7. PubMed ID: 6434435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of depot testosterone administration on serum levels of testosterone, FSH, LH and prolactin.
    Ruiz E; Ortega E; Sanchez-Cantalejo E; Osorio C
    J Endocrinol Invest; 1980; 3(4):385-8. PubMed ID: 6782152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.
    Matsumoto AM; Karpas AE; Paulsen CA; Bremner WJ
    J Clin Invest; 1983 Sep; 72(3):1005-15. PubMed ID: 6411766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
    Wiegelmann W; Solbach HG; Kley HK; Nieschlag E; Rudorff KH; Krüskemper HL
    Horm Res; 1976; 7(1):1-10. PubMed ID: 793974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
    J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of male hypogonadism with testosterone enanthate.
    Snyder PJ; Lawrence DA
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1335-9. PubMed ID: 6777395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone profiles after intramuscular injection of testosterone enanthate in patients with hypogonadism.
    Nakazawa R; Baba K; Nakano M; Katabami T; Saito N; Takahashi T; Iwamoto T
    Endocr J; 2006 Jun; 53(3):305-10. PubMed ID: 16710076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiles of luteinizing hormone, follicle-stimulating hormone, testosterone and prolactin in rams of diverse breeds: effects of contrasting short (8L:16D) and long (16L:8D) photoperiods.
    D'Occhio MJ; Schanbacher BD; Kinder JE
    Biol Reprod; 1984 Jun; 30(5):1039-54. PubMed ID: 6428476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism.
    Wu FC; Balasubramanian R; Mulders TM; Coelingh-Bennink HJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):112-22. PubMed ID: 9920070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum prolactin, FSH, LH and testosterone before and after vasectomy in normal men.
    Nikkanen V; Punnonen R
    Arch Androl; 1982 Jun; 8(4):311-3. PubMed ID: 6810776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of a new long-acting androgen ester: maintenance of physiological androgen levels for 4 months after a single injection.
    Rajalakshmi M; Ramakrishnan PR
    Contraception; 1989 Oct; 40(4):399-412. PubMed ID: 2510967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the correlation between FSH, LH and prolactin serum levels.
    Krause W
    Endokrinologie; 1978 May; 72(2):129-35. PubMed ID: 104865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of exposure to the altitude of 300 meters below sea-level on testosterone, luteinizing hormone, follicle-stimulating hormone and prolactin in man.
    Ajlouni KM; Sliman NA; Najdawi A; Abu-Hajir MM; Arnaout MA
    J Endocrinol Invest; 1988 Sep; 11(8):621-3. PubMed ID: 3149660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the kinetics of injectable testosterone in eugonadal and hypogonadal men.
    Sokol RZ; Palacios A; Campfield LA; Saul C; Swerdloff RS
    Fertil Steril; 1982 Mar; 37(3):425-30. PubMed ID: 6800853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High loading and low maintenance doses of a gonadotropin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle-stimulating hormone, and testosterone in normal men.
    Behre HM; Kliesch S; Pühse G; Reissmann T; Nieschlag E
    J Clin Endocrinol Metab; 1997 May; 82(5):1403-8. PubMed ID: 9141524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.